|
|
|
Insider
Information: |
Vivo Capital Surplus Fund Viii, L.p. |
Relationship: |
10% Owner |
City: |
Palo Alto, |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
1,277,864 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$17,481,324 |
|
|
Total
Shares |
1,277,864 |
|
|
Total
Value |
$17,481,324 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2020-04-03 |
0 |
2020-04-17 |
298,625 |
Premium* |
|
Aligos Therapeutics, Inc. |
ALGS |
10% Owner |
2020-10-20 |
0 |
2020-10-20 |
430,372 |
Premium* |
|
Impel Neuropharma Inc |
IMPL |
10% Owner |
2021-04-27 |
0 |
2023-12-19 |
280,294 |
Premium* |
|
Terns Pharmaceuticals, Inc. |
TERN |
10% Owner |
2022-08-12 |
0 |
2024-04-03 |
268,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2022-08-12 |
4 |
B |
$2.98 |
$3,346,603 |
I/I |
1,123,021 |
1,480,374 |
1.5 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2022-08-15 |
4 |
B |
$2.99 |
$3,642 |
I/I |
1,218 |
1,481,592 |
1.42 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2022-08-16 |
4 |
B |
$2.42 |
$3,630,000 |
I/I |
1,500,000 |
2,981,592 |
1.5 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2022-09-07 |
4 |
B |
$3.60 |
$2,160,000 |
I/I |
600,000 |
3,581,592 |
1.5 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2024-04-01 |
4 |
AS |
$6.99 |
$1,266,008 |
I/I |
(181,117) |
275,772 |
0 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2024-04-02 |
4 |
AS |
$6.65 |
$674,842 |
I/I |
(101,480) |
272,722 |
0 |
% |
|
TERN |
Terns Pharmaceuticals, In... |
10% Owner |
|
2024-04-03 |
4 |
AS |
$6.20 |
$856,009 |
I/I |
(138,066) |
268,573 |
0 |
% |
|
IMPL |
Impel Neuropharma Inc |
10% Owner |
|
2021-04-27 |
4 |
A |
$0.00 |
$1,369,656 |
I/I |
2,309,789 |
280,294 |
0 |
- |
|
IMPL |
Impel Neuropharma Inc |
10% Owner |
|
2021-04-27 |
4 |
B |
$15.00 |
$8,625,000 |
I/I |
575,000 |
349,674 |
1.5 |
- |
|
IMPL |
Impel Neuropharma Inc |
10% Owner |
|
2023-12-15 |
4 |
S |
$0.29 |
$29,000 |
I/I |
(100,000) |
337,608 |
0 |
- |
|
IMPL |
Impel Neuropharma Inc |
10% Owner |
|
2023-12-18 |
4 |
S |
$0.11 |
$26,148 |
I/I |
(237,711) |
308,926 |
0 |
- |
|
IMPL |
Impel Neuropharma Inc |
10% Owner |
|
2023-12-19 |
4 |
S |
$0.08 |
$18,983 |
I/I |
(237,289) |
280,294 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
|
2020-04-03 |
4 |
S |
$13.80 |
$4,140,000 |
I/I |
(300,000) |
339,480 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
|
2020-04-07 |
4 |
S |
$14.20 |
$86,833 |
I/I |
(6,115) |
338,738 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
|
2020-04-15 |
4 |
S |
$15.50 |
$3,345,055 |
I/I |
(215,810) |
312,553 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
|
2020-04-16 |
4 |
S |
$15.20 |
$458,888 |
I/I |
(30,190) |
308,890 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
|
2020-04-17 |
4 |
S |
$15.40 |
$1,302,809 |
I/I |
(84,598) |
298,625 |
0 |
- |
|
ALGS |
Aligos Therapeutics, Inc. |
10% Owner |
|
2020-10-20 |
4 |
B |
$15.00 |
$8,250,000 |
I/I |
550,000 |
430,372 |
1.5 |
- |
|
ALGS |
Aligos Therapeutics, Inc. |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,997,030 |
363,639 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|